Abstract
Lymphocyte chemotaxis plays important roles in immunological reactions, although the mechanism of its regulation is still unclear. We found that the cytosolic Na+-dependent mitochondrial Ca2+ efflux transporter, NCLX, regulates B lymphocyte chemotaxis. Inhibiting or silencing NCLX in A20 and DT40 B lymphocytes markedly increased random migration and suppressed the chemotactic response to CXCL12. In contrast to control cells, cytosolic Ca2+ was higher and was not increased further by CXCL12 in NCLX-knockdown A20 B lymphocytes. Chelating intracellular Ca2+ with BAPTA-AM disturbed CXCL12-induced chemotaxis, suggesting that modulation of cytosolic Ca2+ via NCLX, and thereby Rac1 activation and F-actin polymerization, is essential for B lymphocyte motility and chemotaxis. Mitochondrial polarization, which is necessary for directional movement, was unaltered in NCLX-knockdown cells, although CXCL12 application failed to induce enhancement of mitochondrial polarization, in contrast to control cells. Mouse spleen B lymphocytes were similar to the cell lines, in that pharmacological inhibition of NCLX by CGP-37157 diminished CXCL12-induced chemotaxis. Unexpectedly, spleen T lymphocyte chemotaxis was unaffected by CGP-37157 treatment, indicating that NCLX-mediated regulation of chemotaxis is B lymphocyte-specific, and mitochondria-endoplasmic reticulum Ca2+ dynamics are more important in B lymphocytes than in T lymphocytes. We conclude that NCLX is pivotal for B lymphocyte motility and chemotaxis.
Migration of lymphocytes is one of the fundamental processes of the immune response. In the case of B lymphocytes, circulating naive lymphocytes enter lymph nodes through high endothelial venules, migrate to the B cell area where chemoattractants such as CXCL12 and CXCL13 are highly expressed, and are then activated and differentiated into plasma cells1,2. This directional movement of the cell toward chemoattractants, i.e. chemotaxis, is triggered by an interaction between chemokines and their receptors. The interaction of a chemokine with its receptor (e.g. CXCL12 with CXCR4, and CXCL13 with CXCR5), as well as the subsequent signal transduction pathways, such as MAPKs, PI3K, and NF-κB, have been extensively studied using a variety of cell types, including lymphocytes (see reviews3,4,5,6). However, detailed mechanisms underlying lymphocyte chemotaxis have not yet been clarified.
Ca2+ is an important second messenger which regulates chemotaxis. It is well known that various cellular processes involved in cell motility are Ca2+-sensitive. For example, a rise or oscillation in cytosolic Ca2+ activates cytoskeletal remodelling through the small GTPase Rac1, thereby modulating migration of T lymphocytes, tumour mast cells and podocytes7,8,9. The Ca2+ mobilization is mediated by Ca2+ influx via plasma membrane Ca2+ channels and/or Ca2+ release from intracellular stores such as the endoplasmic reticulum (ER). Various Ca2+ carriers localized at the plasma membrane and in the ER, such as transient receptor potential channels (TRPs), the store-operated Ca2+ entry system (stim1/orai1), ER Ca2+ release channels (inositol trisphosphate receptors), and the ER Ca2+ pump (SERCA), have been implicated in the regulation of the migration of various kinds of cells10,11,12,13,14. As for T lymphocytes, several lines of evidence suggest the involvement of TRPs and stim1/orai1 in Ca2+ mobilization-mediated migration, though little information is available on B lymphocyte migration11,12.
Besides the ER, mitochondria provide an important Ca2+ store inside the cell. Mitochondrial Ca2+ dynamics is determined by influx via the Ca2+ uniporter and efflux via the Na+-Ca2+ exchanger and/or the H+-Ca2+ exchanger15,16. In 2013, MCU, which encodes the mitochondrial Ca2+ uniporter, and MICU, which is a regulator of MCU, were reported to be involved in the migration of human endothelial cells and zebrafish blastomeres17,18. MCU-mediated alterations in cytosolic Ca2+ dynamics and/or the production of mitochondrial reactive oxygen species were implicated in migration, though the exact mechanisms are still unresolved. Moreover, little is known as to whether, and if so, how mitochondrial Ca2+ efflux transporters participate in lymphocyte chemotaxis.
We recently demonstrated that NCLX, a gene responsible for the mitochondrial Na+-Ca2+ exchanger19, acts to provide Ca2+ to the endoplasmic/sarcoplasmic reticulum (ER/SR), and that NCLX-mediated Ca2+ recycling between mitochondria and the ER/SR modulates various cellular functions20,21,22. In B lymphocytes, NCLX is pivotal in maintaining cellular Ca2+ responses to antigens20,21. Considering that cytosolic Ca2+ dynamics participate in the migration of various kinds of cells, we hypothesized that NCLX may participate in lymphocyte migration and/or chemotaxis. In the present study, we studied the roles of NCLX in lymphocyte chemotaxis. We found that NCLX reduction/inhibition markedly suppressed chemotaxis while increasing the random migration of B lymphocytes. In addition, we found that the contributions of NCLX to motility were observed only in B lymphocytes and not in T lymphocytes.
Results
Facilitation of random migration and inhibition of chemotaxis by NCLX silencing in B lymphocytes
We first investigated whether pharmacological intervention of mitochondrial Ca2+ carriers affected the chemotaxis of A20 B lymphocytes. A standard Transwell assay was employed to measure chemotaxis. When CXCL12 was present in the bottom chamber, there was a significant increase in the movement of A20 B lymphocytes toward the bottom chamber; that is, CXCL12 induced chemotaxis of A20 B lymphocytes (Fig. 1). Perturbation of mitochondrial Na+-Ca2+ exchange by CGP-37157 (IC50 = 0.36 μM)23 dose-dependently decreased the extent of chemotaxis, while it did not affect the basal cell movement up to 2 μM. A high concentration of CGP-37157 (20 μM) significantly decreased both chemotaxis and basal cell movement. On the other hand, inhibition of the mitochondrial Ca2+ uniporter by Ru360 (IC50 = 0.2–2 nM)24,25 did not affect the extent of chemotaxis or basal cell movement, even at 50 μM (Fig. 1).
We then tested whether the mitochondrial Na+-Ca2+ exchanger-mediated modulation of chemotaxis occurred in another B lymphocyte cell line, DT40. In heterozygous NCLX knockout DT40 B lymphocytes (NCLX+/−), in which NCLX protein expression was negligible20, CXCL12-induced chemotaxis was significantly suppressed (Supplementary Fig. S1), suggesting that the mitochondrial Na+-Ca2+ exchanger is a key determinant for the chemotaxis of B lymphocytes.
To evaluate individual cell motility, we next performed live-cell imaging using A20 B lymphocytes. Silencing of NCLX using siRNA has previously been shown to reduce NCLX mRNA expression20. We reconfirmed this in the present study by performing quantitative PCR, which resulted in the reduction of NCLX mRNA expression to 45.4 ± 10.8% (N = 3). Single-cell tracking revealed that control siRNA-transfected A20 B lymphocytes (siControl) moved randomly in the absence of CXCL12. Interestingly, under this condition, NCLX knockdown (siNCLX) cells showed higher velocity and mean displacement (Fig. 2a,b,d), indicating that NCLX knockdown facilitated random migration. In siControl cells, a CXCL12 gradient increased motility and induced directional movement toward CXCL12; chemotaxis clearly occurred (Fig. 2a–d). On the contrary, in the siNCLX cells, the CXCL12 gradient did not further increase motility or induce directional movement toward CXCL12 (Fig. 2a–d); this is comparable to the results of the Transwell assays. Similar results were obtained using 2 μM CGP-37157 to block mitochondrial Na+-Ca2+ exchange in A20 B lymphocytes (Supplementary Fig. S2a–c). In addition, random cell movement and migration velocity were higher in NCLX+/− DT40 B lymphocytes compared with that in wild-type (WT) cells (Supplementary Fig. S2d,e), in accord with the facilitation of migration by the reduction or inhibition of NCLX in A20 B lymphocytes (Fig. 2a,b,d, Supplementary Fig. S2). Bath application of CXCL12 did not further augment the random cell movement and the migration velocity of NCLX+/− DT40 B lymphocytes (Supplementary Fig. S2d,e); this is comparable to the results obtained from A20 B lymphocytes (Fig. 2, Supplementary Fig. S2). We confirmed that the expression level of the CXCL12 receptor, CXCR4, was unaffected by NCLX knockdown (Supplementary Fig. S3), suggesting that NCLX reduction/inhibition-mediated alterations of motility were not due to altered CXCL12/CXCR4 interaction. Thus, the silencing of NCLX facilitated random migration while inhibiting chemotaxis in B lymphocytes.
Association of altered cytosolic Ca2+ with NCLX-mediated modulation of cell motility
Considering that various cellular processes involved in motility are Ca2+ sensitive10,11,12,13,14, and that NCLX is pivotal for cytosolic Ca2+ signalling during B cell receptor activation20, we hypothesized that NCLX participates in motility via modulation of cytosolic Ca2+. In siNCLX cells, cytosolic Ca2+ concentration was higher than that in siControl cells in the absence of CXCL12 (Fig. 3a,b). In siControl cells, CXCL12 treatment significantly increased the cytosolic Ca2+. However, it did not further increase the cytosolic Ca2+ in siNCLX cells (Fig. 3a,b). Essentially the same results were obtained by blocking mitochondrial Na+-Ca2+ exchange using CGP-37157 at 2 and 20 μM; i.e. treatment with CGP-37157 increased cytosolic Ca2+ in the absence of CXCL12, and CXCL12 application did not further increase but rather decreased cytosolic Ca2+ when the cells were treated with CGP-37157 (Supplementary Fig. S4). These results well correspond to the data showing that siNCLX cells had higher motility than siControl cells in the absence of CXCL12, and that CXCL12 application induced chemotaxis in siControl cells, but not in siNCLX cells (Fig. 2a,b,d). The importance of cytosolic Ca2+ in cell motility was confirmed by chelating cytosolic Ca2+ during a live-cell chemotaxis assay. Treatment of the cells with 25 μM BAPTA-AM significantly diminished motility, as revealed by decreased mean displacement as well as decreased velocity (Fig. 3c–e). The above findings suggested that altered cytosolic Ca2+ was associated with NCLX-mediated modulation of cell motility.
Facilitation of F-actin polymerization and Rac1 localization in NCLX knockdown cells
In order to elucidate how cytosolic Ca2+ alteration modulates cell motility in NCLX-silenced cells, we next focused on actin rearrangement and localization of Rac1, a member of a small GTPase family, because both had been reported to be Ca2+-sensitive and to be key factors determining cell migration and chemotaxis8,9,26,27,28,29,30,31. The distribution of F-actin was evaluated by staining the cells with fluorescently-labelled phalloidin. In siControl cells, F-actin was confined to a small area in the absence of CXCL12. On the other hand, siNCLX cells had a less confined F-actin distribution than siControl cells. After bath application of CXCL12, the F-actin region was significantly expanded in siControl cells but was unaltered in siNCLX cells (Fig. 4). Localization of Rac1 was examined by immunocytochemistry. As clearly shown in Supplementary Fig. S5, Rac1 was more diffusely distributed in siNCLX cells than in siControl cells in the absence of CXCL12. After bath application of CXCL12, the Rac1 region expanded in siControl cells but contracted in siNCLX cells. The effects of NCLX knockdown and/or CXCL12 application on F-actin and Rac1 localization were quite similar in pattern to the effects on cytosolic Ca2+ and cell motility. Accordingly, it was suggested that the NCLX knockdown-mediated increase of cytosolic Ca2+ facilitated F-actin formation and Rac1 localization, resulting in the augmentation of random cell migration.
Association of CXCL12-induced polarization of mitochondria with directional cell movement of A20 B lymphocytes
At this point, we were faced with the question of why directional movement towards CXCL12, i.e. chemotaxis, did not occur in siNCLX cells, in spite of the increased random cell migration. In seeking the answer, we analysed mitochondrial polarization (Fig. 5), which had been reported to be important for directional cell movement in a variety of cell types32,33,34,35. In siControl cells, mitochondria stained with MitoTracker Orange were distributed evenly within the cell, and CXCL12 application induced mitochondrial accumulation in one part of the cell. In siNCLX cells, the mitochondrial distribution was similar to siControl cells in the absence of CXCL12, despite the alteration of F-actin formation and Rac1 localization (Fig. 4 and Supplementary Fig. S5). CXCL12 application failed to induce mitochondrial polarization in the siNCLX cells. Thus, the CXCL12-induced mitochondrial polarization may be associated with the directional movement of the cell and chemotaxis but not with velocity and extent of movement. Similar results were obtained using NCLX+/− DT40 B lymphocytes (Supplementary Fig. S6).
B lymphocyte specificity of NCLX-mediated modulation of chemotaxis
Finally, we examined whether the above findings were applicable to native B lymphocytes. We performed live-cell imaging of isolated mouse spleen B lymphocytes and evaluated chemotaxis toward CXCL12 (Fig. 6a–c), in comparison with T lymphocytes (Fig. 6d–f). In both B and T lymphocytes isolated from mouse spleen, the CXCL12 gradient induced chemotaxis (Fig. 6a,b,d,e). Blocking NCLX with 2 μM CGP-37157 significantly suppressed B lymphocyte chemotaxis and motility in the presence of CXCL12 (Fig. 6a–c). These results suggested that NCLX had important roles in the chemotaxis of mouse spleen B lymphocytes, similar to B lymphocyte cell lines. In contrast, CGP-37157 did not affect the chemotaxis or motility of T lymphocytes (Fig. 6d–f), indicating that the contribution of NCLX to chemotaxis was specific to B lymphocytes.
NCLX-mediated mitochondria-ER Ca2+ recycling is pivotal for the cytosolic Ca2+ response to B cell receptor stimulation20 and NCLX-mediated regulation of cytosolic Ca2+ is associated with the motility of B lymphocytes (Fig. 3, Supplementary Fig. S4). These facts prompted us to compare B and T lymphocytes in terms of their expression of Ca2+ carriers and a Ca2+ binding protein that determine cytosolic Ca2+ dynamics (Fig. 7a). Interestingly, the mRNA levels of factors involved in mitochondria-ER Ca2+ dynamics, such as NCLX, the possible mitochondrial H+/Ca2+ exchanger Letm1, the ER Ca2+ pump SERCA3, three ER inositol trisphosphate receptor Ca2+ release channels (IP3Rs 1–3), and the ER Ca2+ binding protein calreticulin, were significantly higher in B lymphocytes than in T lymphocytes. It should be noted that the expression levels of mitochondrial adenine nucleotide translocator 2 (ANT2) and ATP synthase subunit ATP5b were comparable between B and T lymphocytes, suggesting that the cellular content of mitochondria is similar in the two cell types. In addition, the expression level of orai1, which mediates Ca2+ influx across the plasma membrane in response to ER Ca2+ depletion, was also higher in B lymphocytes than in T lymphocytes. On the other hand, the expression levels of other Ca2+ carriers in plasma membrane, such as the Na+-Ca2+ exchangers NCX1–3 and the Ca2+ pump PMCA1, were comparable between B and T lymphocytes. These results suggest that the contribution of organelle Ca2+ dynamics to cytosolic Ca2+ was larger in B lymphocytes than in T lymphocytes. In fact, the cytosolic Ca2+ response to antigen receptor stimulation was sensitive to the mitochondrial Na+-Ca2+ exchange blocker CGP-37157 in B lymphocytes but not in T lymphocytes (Fig. 7b,c). The larger contribution of organelle Ca2+ dynamics may be related to the larger contribution of NCLX to chemotaxis in B lymphocytes than in T lymphocytes.
Discussion
NCLX was identified as a mitochondrial Na+-Ca2+ exchanger by Palty et al.19, and there is a rapidly growing literature on the physiological and pathophysiological roles of NCLX in a variety of cell types, including pancreatic β cells, astrocytes, cardiomyocytes, and B lymphocytes20,21,22,36,37,38.
In the present study, we showed that NCLX modulates B lymphocyte motility by regulating cytosolic Ca2+, and that this is a minor mechanism in T lymphocytes. Under control conditions, a chemokine induces actin polymerization through Rac1, possibly via increasing cytosolic Ca2+ (Figs 3 and 4, Supplementary Figs S4 and S5;8,26,27,29), and induces mitochondrial polarization (Fig. 5;33,34), resulting in increased motility with directionality towards the chemokine. On the other hand, NCLX reduction/inhibition increases cytosolic Ca2+ even in the absence of chemokine (Fig. 3 and Supplementary Fig. S4), probably due to increased Ca2+ leak from the ER, as we reported previously20. This Ca2+ increase may activate Rac1 and facilitate actin polymerization in many parts of the cell, resulting in augmentation of random movement (Figs 2 and 4, Supplementary Figs S2 and S5). However, the chemokine may hardly be able to induce the further Rac1 activation or actin polarization needed for chemotaxis under this already disorganized condition (Fig. 4 and Supplementary Fig. S5). Moreover, the failure of mitochondrial polarization in response to a chemokine may lead to impaired chemotaxis of cells with reduced or inhibited NCLX, in spite of the increased random migration. The mechanism underlying the prevention of mitochondrial polarization by NCLX reduction/inhibition remains to be clarified. NCLX, or Ca2+ extruded by NCLX, is likely to be important for proper localization of mitochondria in the cell, because silencing NCLX disrupts the structural coordination of mitochondria and the ER, as shown in our previous study20. We propose here that CXCL12-CXCR4 chemotaxis signalling is associated with NCLX and/or mitochondrial polarization. However, since cytosolic Ca2+ affects a wide range of protein functions, other processes besides those examined in this study might be affected by NCLX reduction/inhibition. Further studies are needed to obtain the comprehensive framework of lymphocyte chemotaxis.
There is a limitation in our siRNA experiments. Since siRNA is known to have off-target effects, experiments with several kinds of siRNA are ideal39. The experiments were not durable in our experimental system because of relatively low reductions of NCLX mRNA expression with other four siRNAs tested. However, it is notable that similar results to NCLX siRNA experiments in A20 B lymphocytes were obtained by pharmacological inhibition of NCLX in A20 and spleen B lymphocytes and by NCLX knockout in DT40 B lymphocytes. This fact strongly suggests that the off-target effects is small, if any.
Mitochondrial polarization may have another role: to supply ATP to myosin for contraction33. Therefore, the impairment of chemotaxis by NCLX suppression may be caused by an inadequate supply of ATP from the mitochondria to myosin. An increase in cytosolic and mitochondrial Ca2+ has been reported to activate mitochondrial aspartate/glutamate carriers and dehydrogenases, respectively, resulting in an increased production of NADH and ATP in mitochondria40,41. However, the cellular ATP level, measured by luciferase assay, was comparable between siControl cells and siNCLX cells (the ATP content of siNCLX cells without CXCL12 was 102.4 ± 6.5% of siControl cells without CXCL12, N = 4). Moreover, CXCL12 did not change the ATP level in either siControl cells or siNCLX cells (in siControl cells and siNCLX cells, the ATP content in the presence of CXCL12 was 100.7 ± 6.5% and 105.0 ± 4.2% of that in the absence of CXCL12, respectively, N = 4). These data suggest that the impairment of chemotaxis by NCLX reduction/inhibition was not due to impaired ATP supply.
As far as we know, this is the first report which demonstrates the involvement of a mitochondrial Ca2+ carrier in the regulation of B lymphocyte chemotaxis. Recent findings suggest that the mitochondrial Ca2+ uniporter MCU and its accessory protein MICU play roles in the motility of human endothelial cells and zebrafish blastomeres, respectively17,18. However, in the present study, the contribution of MCU to the chemotaxis of A20 lymphocytes was small (Fig. 1). Moreover, the mRNA expression levels of MCU in mouse spleen B and T lymphocytes were extremely low (6.4 × 10−5 ± 1.5 × 10−5 and 3.7 × 10−5 ± 1.5 × 10−5 in mouse spleen B and T lymphocytes, respectively (normalised to glyceraldehyde-3-phosphate dehydrogenase (GAPDH), N = 3) and 0.002 in A20 B lymphocytes (N = 1)), suggesting that the contribution of MCU to chemotaxis in native lymphocytes, if any, is small.
The most unexpected finding was the difference in NCLX contribution to chemotaxis between B lymphocytes and T lymphocytes (Figs 6 and 7a). The particularly important role of NCLX in B lymphocytes may be attributable to the difference in Ca2+ dynamics between B and T lymphocytes, that is, the larger contribution of NCLX-mediated mitochondria-ER Ca2+ dynamics to cytosolic Ca2+ in B lymphocytes than in T lymphocytes (Fig. 7b,c).
It would be interesting to see if NCLX participates in immune responses, such as antibody production, in vivo. However, this would be rather difficult because non-specific effects of the mitochondrial Na+-Ca2+ exchange blocker CGP-37157 on L-type Ca2+ channels, which are important in the heart, nerve and muscle, cannot be excluded42, and retention of CGP-37157 in the body is extremely low43. The production of complete NCLX knockout mice would facilitate such studies.
Methods
Solutions and drugs
Ru360 and BAPTA-AM were purchased from Sigma-Aldrich. CGP-37157 was purchased from Tocris Bioscience. The stock solution was prepared with DMSO, the final concentration of which was 0.01–0.1%.
Cell culture and transfection
Maintenance of murine A20 B lymphocytes and transfection with siRNA were performed as previously described20.
Transwell chemotaxis assay
Assays were performed using Transwells equipped with polycarbonate membrane filters (8-μm pore; Corning) according to the protocol by Hara-Chikuma et al.44. The membrane was coated with PBS containing 10 μg/ml fibronectin (Sigma-Aldrich) for 30 min, washed twice, and incubated in RPMI 1640 containing 0.1% BSA for 30 min at 37 °C. The lower chamber was filled with RPMI 1640 + 0.1% BSA in the presence or absence of 100 ng/ml recombinant murine CXCL12 (PeproTech). Cells were starved for 1 hr in serum-free RPMI 1640 with 0.1% BSA, then applied to the upper chamber. The migrated cells were counted after 5 hrs by flow cytometry analysis (FACSCalibur; BD Biosciences), and expressed as a percentage of the input cells. When pharmacological inhibitors were used, cells were pretreated with the inhibitors for 20 min at 37 °C, and the inhibitors were added to both chambers.
Real-time chemotaxis assay
Assays were performed with a μ-Slide Chemotaxis3D (ibidi GmbH) according to the manufacturer’s instructions. Cells were conjugated with collagen I gel and applied to the observation area in the presence or absence of 100 ng/ml CXCL12 in one side of the reservoir. The chamber was placed in a CO2-incubator (Tokai hit) on the stage of a fluorescence microscope (ECLIPSE Ti; Nikon). Transmission images of cells were obtained every 2 min over 8 hrs using a digital CCD camera (ORCA-R2; Hamamatsu Photonics), and analyzed using a particle tracking tool of AQUACOSMOS software (Hamamatsu Photonics), a filtering tool of ImageJ (NIH) and a Chemotaxis and Migration tool (ibidi GmbH). Cells which moved directionally toward CXCL12 were evaluated by the position in the 90-degree area facing CXCL12 at the end of the experiment. The extent of chemotaxis was expressed as the percentage of directionally moved cells which moved over a distance equal to the average cell size (A20, ≥15 μm; splenocytes, ≥10 μm). When pharmacological inhibitors were used, they were applied to both sides of the reservoir.
Measurement of Ca2+ i in single cells
Cytosolic Ca2+ was measured as described previously20. Cells which were stimulated with or without 100 ng/ml CXCL12 for 2 hrs were loaded with 5 μM Fura 2-AM, and transferred to a cover glass coated with fibronectin. The fluorescence images of the cells were recorded using an EM-CCD camera (ImagEM, Hamamatsu Photonics) mounted on a fluorescence microscope (ECLIPSE Ti) and analyzed with AQUACOSMOS software.
F-actin polymerization assay
Cells were applied to cover glasses coated with 10 μg/ml fibronectin, starved for 1 hr at 37 °C in serum-free RPMI 1640 with 0.1% BSA, and incubated with or without 100 ng/ml CXCL12 for 2 hrs. After fixation with 3.7% formalin for 15 min at 37 °C, cells were permeabilised with 0.1% Triton-X/PBS for 10 min, blocked with 1% BSA/PBS for 30 min, and stained with Alexa Fluor 488 phalloidin (Invitrogen) and DAPI (Dojindo). Immunofluorescence images were obtained using a confocal microscope (LSM 710; Zeiss). A high intensity phalloidin signal was defined as a fluorescence intensity of more than 5000 a.i. and was expressed as % of cell area.
Analysis of mitochondrial polarization
Cells were applied to cover glasses coated with 10 μg/ml fibronectin, starved for 1 hr at 37 °C in serum-free RPMI 1640 with 0.1% BSA, and incubated with or without 100 ng/ml CXCL12 for 2 hrs. Then cells were stained with 1 μM MitoTracker Orange (Invitrogen), and images were obtained using a confocal microscope (LSM 710; Zeiss). Mitochondria-polarized cells were defined as cells in which the mitochondria were located within one-half of the cell area.
Isolation of mouse spleen B and T lymphocytes
Female 6–10-wk-old Balb/c mice were purchased from Japan SLC. All experimental procedures were conducted in accordance with the guidelines of the Research Center of Kyoto University Graduate School of Medicine and Regulations for Animal Research at University of Fukui. Procedures were approved by the Committee on Animal Research of Kyoto University Graduate School of Medicine and the Faculty of Medical Sciences, University of Fukui. Single splenocytes were obtained by standard procedures45, and then B and T lymphocytes were isolated by negative selection using the MACS system (B cell isolation kit (#130–090–862) and CD4+ T cell kit (#130–095–248); Miltenyi Biotec K.K.), according to the manufacturer’s instructions.
Quantitative PCR analysis
Quantitative PCR analysis was performed as described previously20,22. The primers are listed in Supplementary Table S1.
Statistical analysis
All data are presented as mean ± SEM of independent recordings. The number of independent experiments and the number of cells per recording are presented as N and n, respectively. In the microscopy measurements, the responses from n individual cells were averaged for each recording. Then the statistical evaluation was performed on averaged responses from N independent recordings. Each experiment was repeated independently more than three times. Statistical analyses were performed by one-way ANOVA multiple comparisons (SigmaPlot, Systat Software Inc., San Jose, CA, USA). Post hoc and two-group comparisons were performed using the Student–Newman–Keuls test and the unpaired Student’s t test, respectively. P < 0.05 was considered significant.
Additional Information
How to cite this article: Kim, B. et al. Roles of the mitochondrial Na+-Ca2+ exchanger, NCLX, in B lymphocyte chemotaxis. Sci. Rep. 6, 28378; doi: 10.1038/srep28378 (2016).
Supplementary Material
Acknowledgments
This work was supported in part by the JSPS KAKENHI grant Numbers 23390042 and 26670101 (S.M.), 23689011 (A.T.), and 22790211 (B.K.), and in part by Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program (S.M. and M.H.).
Footnotes
Author Contributions S.M. designed research; B.K., M.H. and A.T. performed the research; B.K., A.T. and S.M. analysed the data; A.T. and S.M. wrote the paper.
References
- Stein J. V. & Nombela-Arrieta C. Chemokine control of lymphocyte trafficking: a general overview. Immunology 116, 1–12 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mountz J. D., Wang J. H., Xie S. & Hsu H. C. Cytokine regulation of B-cell migratory behavior favors formation of germinal centers in autoimmune disease. Discov Med. 11, 76–85 (2011). [PMC free article] [PubMed] [Google Scholar]
- Homey B., Muller A. & Zlotnik A. Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2, 175–184 (2002). [DOI] [PubMed] [Google Scholar]
- Teicher B. A. & Fricker S. P. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16, 2927–2931 (2010). [DOI] [PubMed] [Google Scholar]
- Moll N. M. & Ransohoff R. M. CXCL12 and CXCR4 in bone marrow physiology. Expert Rev Hematol 3, 315–322 (2010). [DOI] [PubMed] [Google Scholar]
- Finch D. K., Ettinger R., Karnell J. L., Herbst R. & Sleeman M. A. Effects of CXCL13 inhibition on lymphoid follicles in models of autoimmune disease. Eur J Clin Invest. 43, 501–509 (2013). [DOI] [PubMed] [Google Scholar]
- Tian D. et al. Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels. Sci Signal 3, ra77 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Babich A. & Burkhardt J. K. Coordinate control of cytoskeletal remodeling and calcium mobilization during T-cell activation. Immunol Rev. 256, 80–94 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wu M., Wu X. & De Camilli P. Calcium oscillations-coupled conversion of actin travelling waves to standing oscillations. Proc Natl Acad Sci USA 110, 1339–1344 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fabian A. et al. TRPC1 channels regulate directionality of migrating cells. Pflugers Arch 457, 475–484 (2008). [DOI] [PubMed] [Google Scholar]
- Ma J., McCarl C. A., Khalil S., Luthy K. & Feske S. T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells. Eur J Immunol 40, 3028–3042 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kuras Z., Yun Y. H., Chimote A. A., Neumeier L. & Conforti L. KCa3.1 and TRPM7 channels at the uropod regulate migration of activated human T cells. PLoS One 7, e43859 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thompson M. D. et al. Glutathione adducts on sarcoplasmic/endoplasmic reticulum Ca2+ ATPase Cys-674 regulate endothelial cell calcium stores and angiogenic function as well as promote ischemic blood flow recovery. J Biol Chem. 289, 19907–19916 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Solanes P. et al. Space exploration by dendritic cells requires maintenance of myosin II activity by IP3 receptor 1. EMBO J. 34, 798–810 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 79, 1127–1155 (1999). [DOI] [PubMed] [Google Scholar]
- Rizzuto R., De Stefani D., Raffaello A. & Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol. 13, 566–578 (2012). [DOI] [PubMed] [Google Scholar]
- Hoffman N. E. et al. MICU1 motifs define mitochondrial calcium uniporter binding and activity. Cell Rep. 5, 1576–1588 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prudent J. et al. Bcl-wav and the mitochondrial calcium uniporter drive gastrula morphogenesis in zebrafish. Nat Commun 4, 2330 (2013). [DOI] [PubMed] [Google Scholar]
- Palty R. et al. NCLX is an essential component of mitochondrial Na+/Ca2+ exchange. Proc Natl Acad Sci USA 107, 436–441 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim B., Takeuchi A., Koga O., Hikida M. & Matsuoka S. Pivotal role of mitochondrial Na+-Ca2+ exchange in antigen receptor mediated Ca2+ signalling in DT40 and A20 B lymphocytes. J Physiol. 590, 459–474 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim B., Takeuchi A., Koga O., Hikida M. & Matsuoka S. Mitochondria Na+-Ca2+ exchange in cardiomyocytes and lymphocytes. Adv Exp Med Biol. 961, 193–201 (2013). [DOI] [PubMed] [Google Scholar]
- Takeuchi A., Kim B. & Matsuoka S. The mitochondrial Na+-Ca2+ exchanger, NCLX, regulates automaticity of HL-1 cardiomyocytes. Sci Rep. 3, 2766 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cox D. A., Conforti L., Sperelakis N. & Matlib M. A. Selectivity of inhibition of Na+-Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157. J Cardiovasc Pharmacol 21, 595–599 (1993). [DOI] [PubMed] [Google Scholar]
- Ying W. L., Emerson J., Clarke M. J. & Sanadi D. R. Inhibition of mitochondrial calcium ion transport by an oxo-bridged dinuclear ruthenium ammine complex. Biochemistry 30, 4949–4952 (1991). [DOI] [PubMed] [Google Scholar]
- Matlib M. A. et al. Oxygen-bridged dinuclear ruthenium amine complex specifically inhibits Ca2+ uptake into mitochondria in vitro and in situ in single cardiac myocytes. Journal of Biological Chemistry 273, 10223–10231 (1998). [DOI] [PubMed] [Google Scholar]
- Price L. S. et al. Calcium signaling regulates translocation and activation of Rac. J Biol Chem. 278, 39413–39421 (2003). [DOI] [PubMed] [Google Scholar]
- Idzko M. et al. Lysophosphatidic acid induces chemotaxis, oxygen radical production, CD11b up-regulation, Ca2+ mobilization, and actin reorganization in human eosinophils via pertussis toxin-sensitive G proteins. J Immunol 172, 4480–4485 (2004). [DOI] [PubMed] [Google Scholar]
- Grunicke H. H. Coordinated regulation of Ras-, Rac-, and Ca2+-dependent signaling pathways. Crit Rev Eukaryot Gene Expr. 19, 139–169 (2009). [DOI] [PubMed] [Google Scholar]
- Faroudi M. et al. Critical roles for Rac GTPases in T-cell migration to and within lymph nodes. Blood 116, 5536–5547 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rougerie P. & Delon J. Rho GTPases: masters of T lymphocyte migration and activation. Immunol Lett. 142, 1–13 (2012). [DOI] [PubMed] [Google Scholar]
- Merriam E. B. et al. Synaptic regulation of microtubule dynamics in dendritic spines by calcium, F-actin, and drebrin. J Neurosci. 33, 16471–16482 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li Z., Okamoto K., Hayashi Y. & Sheng M. The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119, 873–887 (2004). [DOI] [PubMed] [Google Scholar]
- Campello S. et al. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J Exp Med 203, 2879–2886 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanchez-Madrid F. & Serrador J. M. Mitochondrial redistribution: adding new players to the chemotaxis game. Trends Immunol 28, 193–196 (2007). [DOI] [PubMed] [Google Scholar]
- Zhao J. et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32, 4814–4824 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nita, II et al. The mitochondrial Na+/Ca2+ exchanger upregulates glucose dependent Ca2+ signalling linked to insulin secretion. PLoS One 7, e46649 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Parnis J. et al. Mitochondrial exchanger NCLX plays a major role in the intracellular Ca2+ signaling, gliotransmission, and proliferation of astrocytes. J Neurosci 33, 7206–7219 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takeuchi A., Kim B. & Matsuoka S. The destiny of Ca2+ released by mitochondria. J Physiol Sci. 65, 11–24 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jackson A. L. & Linsley P. S. Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov. 9, 57–67 (2010). [DOI] [PubMed] [Google Scholar]
- McCormack J. G., Halestrap A. P. & Denton R. M. Role of calcium ions in regulation of mammalian intramitochondrial metabolism. Physiol Rev. 70, 391–425 (1990). [DOI] [PubMed] [Google Scholar]
- Contreras L. et al. Ca2+ Activation kinetics of the two aspartate-glutamate mitochondrial carriers, aralar and citrin: role in the heart malate-aspartate NADH shuttle. J Biol Chem. 282, 7098–7106 (2007). [DOI] [PubMed] [Google Scholar]
- Thu le T., Ahn J. R. & Woo S. H. Inhibition of L-type Ca2+ channel by mitochondrial Na+-Ca2+ exchange inhibitor CGP-37157 in rat atrial myocytes. Eur J Pharmacol 552, 15–19 (2006). [DOI] [PubMed] [Google Scholar]
- Lee B. et al. Inhibition of mitochondrial Na+-Ca2+ exchanger increases mitochondrial metabolism and potentiates glucose-stimulated insulin secretion in rat pancreatic ilets. Diabetes 52, 965–973 (2003). [DOI] [PubMed] [Google Scholar]
- Hara-Chikuma M. et al. Chemokine-dependent T cell migration requires aquaporin-3-mediated hydrogen peroxide uptake. J Exp Med. 209, 1743–1752 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tan J. K. & Watanabe T. Murine spleen tissue regeneration from neonatal spleen capsule requires lymphotoxin priming of stromal cells. J Immunol 193, 1194–1203 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.